Dpharma, Pharma, Asiaply, Esafe, Inix, JCY, Versatl, YSPSAH

TheEdge Wed, Jul 15, 2020 01:36pm - 3 years View Original


KUALA LUMPUR (July 15): theedgemarkets.com highlighted eight stocks at Bursa Malaysia’s afternoon close today. Two stocks displayed positive momentum while six stocks showed negative momentum.

The stocks with positive momentum were:

Duopharma Biotech Bhd – up 23 sen or 14.11% at RM1.86

Pharmaniaga Bhd – up 47 sen or 20.89% at 2.72 sen

The stocks with negative momentum were:

Asia Poly Holdings Bhd – up three sen or 9.68% at 34 sen

Eversafe Rubber Bhd – down half a sen or 2.33% at 21 sen

Inix Technologies Holdings Bhd – up half a sen or 5.26% at 10 sen

JCY International Bhd – up 6.5 sen or 16.05% at 47 sen

Versatile Creative Bhd – up 7.5 sen or 16.13% at 54 sen

YSP Southeast Asia Holding Bhd – up six sen or 2.6% at RM2.37

The list of stocks with momentum is generated using a proprietary mathematical algorithm highlighting stocks with a build-up in trading volume and price. The algorithm differentiates between stocks that exhibit positive (+ve) momentum and negative (-ve) momentum.

This list is not a buy or sell recommendation. It merely tells you which stocks are seeing higher than normal volume and price movements.

The share price may move up or down from this point. But the “+ve” (suggesting a rising price trend on volume) and “-ve” (suggesting a falling price trend on volume) indicators should give readers a better idea of what the market is buying and when to sell. Note also that momentum generally only persists for a short period of time.

However, each stock has an accompanying fundamental score and valuation score to help readers evaluate the attractiveness of the stocks, if they want to ride the momentum.

The content is a snapshot from Publisher. Refer to the original content for accurate info. Contact us for any changes.






Related Stocks

ASIAPLY 0.060
BURSA 7.360
DPHARMA 1.150
ESAFE 0.200
JCY 0.255
PGF 1.830
PHARMA 0.335
VERSATL 0.645
ZENTECH 0.020

Comments

Login to comment.